WHERE ADC MANUFACTURING IS DESIGNED, CONTROLLED, TRANSFERRED - & STRETEGICALLY OUTSOURCED - BEFORE IT IS SCALED

ADC innovation is accelerating rapidly. Pipelines are advancing into clinical and commercial stages faster than ever before.

‍

Yet across the industry, a pattern is emerging:

• Scientifically strong ADCs prove operationally fragile
• CMC strategies lack lifecycle resilience
• Tech transfers expose analytical and knowledge gaps
• Outsourcing relationships are structured too late - or too transactionally
• Engineering constraints surface under pressure.

These are not production problems; they are design, transfer, and partnership problems.

‍

ADC Manufacturing & Outsourcing focuses on the interfaces:

• Where discovery meets development
• Where CMC strategy meets regulatory expectation
• Where innovators select and align with CDMO partners
• Where development programmes transition into GMP environments
• Where engineering decisions define scalability and containment

‍

This is where long-term manufacturing success is shaped.

‍

‍

Why Design, CMC, Tech Transfer, Engineering & Outsourcing Together?

‍

ADC manufacturing challenges do not sit within a single function. And they do not sit within a single organisation.

• Design decisions affect manufacturability and partner selection
• CMC strategy determines regulatory flexibility across sites
• Outsourcing models shape knowledge retention and risk distribution
• Tech transfer exposes gaps between development intent and GMP execution
• Engineering determines whether processes are safe, scalable, and repeatable

‍

ADC Manufacturing & Outsourcing addresses ADC manufacturing as an integrated ecosystem, spanning innovator and CDMO environments.

‍

‍

Core Themes for 2026:

‍

Designing ADCs for Manufacturability & Transfer

Embedding manufacturability, lifecycle flexibility, and outsourcing readiness into early development.
Linker-payload strategy, conjugation architecture, and early CQA identification.

‍

CMC Strategy & Regulatory Architecture

Building resilient CMC frameworks from early development through commercial readiness.
Comparability planning, lifecycle management, and regulatory alignment across internal and outsourced networks.

‍

Strategic Outsourcing & CDMO Alignment

Selecting and structuring CDMO partnerships for potent ADC programmes.
Balancing control, flexibility, and speed.
Managing knowledge transfer, governance, and long-term collaboration models.

‍

Right-First-Time Tech Transfer

Governance frameworks that reduce friction between development and GMP sites.
Analytical and process transfer strategies that minimise variability and regulatory risk.

‍

Engineering & Containment Strategy for Potent Modalities

Facility design for high-potency payload handling.
Occupational exposure control and containment architecture.
Engineering solutions across conjugation, purification, and formulation.
Digital and PAT-enabled manufacturing concepts.

‍

‍

What Makes #ADCMan2026 Different?

‍

This is not a large-scale production conference. It does not focus on retrospective GMP success stories. Instead, ADC Manufacturing & Outsourcing concentrates on:

• Decision-making before GMP execution
• Translational challenges between development and manufacturing
• Cross-functional alignment between science, regulation, engineering, and outsourcing partners
• Designing manufacturing and outsourcing strategies that scale successfully

‍

This event is the strategic complement to ADC Manufacturing Europe (Dublin, 28 - 29 October 2026), which focuses on manufacturing execution and operational scale.
The UK defines the strategy. Ireland delivers the scale.

‍

Why Does the Market Need this Event?

‍

The global ADC landscape is entering a decisive phase. Scientific innovation has accelerated dramatically. Manufacturing governance, CMC strategy, and outsourcing frameworks have not kept pace.

‍

ADCs combine:

• Biologics
• Highly-potent small molecules
• Advanced conjugation chemistry
• Sophisticated analytics
• Strict safety and engineering requirements

‍

As programmes advance, the industry is increasingly encountering:

• ADCs that are innovative but difficult to scale
• CMC strategies that limit regulatory flexibility
• Outsourcing models that expose knowledge gaps
• Tech transfers that reveal analytical inconsistencies
• Engineering misalignment discovered too late

‍

Most conferences focus on downstream GMP execution. The market lacks a dedicated forum addressing the earlier strategic decisions that determine manufacturability, comparability, and long-term supply reliability - across both innovator and CDMO environments.

‍

ADC Manufacturing & Outsourcing fills that gap.

‍

‍

Who Should Attend?

‍

This conference is designed for senior and specialist professionals responsible for designing, transferring, and outsourcing ADC manufacturing programmes, including:

• CMC & MSAT leaders
• Process and analytical development scientists
• Tech transfer and manufacturing strategy leads
• Regulatory affairs and quality strategists
• Engineering and facility design experts
• Strategic outsourcing and alliance management leads
• Innovator biotech and advanced CDMO teams

‍

If your role influences how an ADC is designed, governed, engineered, or outsourced... this is your forum.

‍

‍

Why London, UK?

‍

The UK is a global hub for:

• ADC discovery and translational science
• CMC and regulatory strategy leadership
• Engineering and containment innovation
• CDMO and partnership ecosystems supporting potent modalities

‍

London provides a natural meeting point for the decision-makers shaping ADC manufacturing pathways worldwide.